General Information of Drug (ID: DMQSPFS)

Drug Name
Encaleret Drug Info
Synonyms
ENCALERET; 787583-71-5; EF8081AQ6G; CHEMBL1672973; Encaleret (USAN); ENCALERET [USAN]; 2'-((1R)-1-(((1-(4-chloro-3-fluorophenyl)-2-methylpropan-2-yl)amino)-(2R)-2-hydroxypropoxy)ethyl)-3-methyl(1,1'-biphenyl)-4-carboxylic acid; 2'-((1R)-1-(((2R)-3-((1-(4-chloro-3-fluorophenyl)-2-methylpropan-2-yl)amino)-2-hydroxypropyl)oxy)ethyl)-3-methyl-1,1'-biphenyl-4-carboxylic acid; Encaleret [INN]; (1,1'-Biphenyl)-4-carboxylic acid, 2'-((1R)-1-((2R)-3-((2-(4-chloro-3-fluorophenyl)-1,1-dimethylethyl)amino)-2-hydroxypropoxy)ethyl)-3-methyl-; Encaleret [USAN:INN]; UNII-EF8081AQ6G; ENCALERET [WHO-DD]; CLTX305; SCHEMBL482046; CLTX-305; GTPL9474; BDBM50337103; AKOS040751679; 4-[2-[(1R)-1-[(2R)-3-[[1-(4-chloro-3-fluorophenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]phenyl]-2-methylbenzoic acid; D10068; Q27277151; 2''-((1R)-1-{(2R)-3-[1-(4-Chloro-3-fluorophenyl)-2-methylpropan-2-ylamino]-2-hydroxypropoxy}ethyl)-3-methylbiphenyl-4-carboxylic acid hemisulfate; 2'-((1R)-1-((2R)-3-((1-(4-CHLORO-3-FLUOROPHENYL)-2-METHYLPROPAN-2-YL)AMINO)-2-HYDROXYPROPOXY)ETHYL)-3-METHYL(1,1'-BIPHENYL)-4-CARBOXYLIC ACID
Indication
Disease Entry ICD 11 Status REF
Autosomal dominant hypocalcemia 5A50.0Y Phase 3 [1]
Cross-matching ID
PubChem CID
46917559
TTD Drug ID
DMQSPFS

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Preclinical Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cinacalcet DMCX0K3 Hyperparathyroidism 5A51 Approved [3]
Etelcalcetide DMHP9BL Secondary hyperparathyroidism 5A51.1 Approved [4]
ASP7991 DM3TN1A Hyperparathyroidism 5A51 Phase 2 [5]
MK-5442 DMHTIGU Osteoporosis FB83.0 Phase 2 [6]
ATF-936 DMWGKHZ Osteoporosis FB83.0 Phase 1 [7]
AXT-914 DM7ZU3B Osteoporosis FB83.0 Phase 1 [8]
R-568 DM5NWPD N. A. N. A. Discontinued in Phase 2 [9]
Ronacaleret DM10ZJP Osteoporosis FB83.0 Discontinued in Phase 2 [10]
NPS-2143 DMQPXLF Osteoporosis FB83.0 Discontinued in Phase 2 [11]
NPS-2390 DMMRY0Z Cerebrovascular ischaemia 8B1Z Preclinical [12]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Extracellular calcium-sensing receptor (CASR) TTBUYHA CASR_HUMAN Antagonist [2]

References

1 ClinicalTrials.gov (NCT05680818) CALIBRATE: A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1). U.S.National Institutes of Health.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2023. Adis Insight
3 Clinical pipeline report, company report or official report of Amgen (2009).
4 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
5 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035616)
6 Antagonist for calcium-sensing receptor. JTT-305/MK-5442. Clin Calcium. 2011 Jan;21(1):89-93.
7 ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans. Bone. 2011 Aug;49(2):233-41.
8 AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women. Bone. 2014 Jul;64:204-10.
9 Mixed-effects modeling of the pharmacodynamic response to the calcimimetic agent R-568. Clin Pharmacol Ther. 1999 Jan;65(1):40-9.
10 Clinical pipeline report, company report or official report of GlaxoSmithKline (2009).
11 Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Abeta42 prompted by exogenous fibrillary or soluble Abeta25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease. Biochim Biophys Acta. 2013 Oct;1832(10):1634-52.
12 The Extracellular Calcium-Sensing Receptor (CASR) Regulates Gonadotropins-Induced Meiotic Maturation of Porcine Oocytes.Biol Reprod.2015 Dec;93(6):131.